{"resourceType": "ArtifactAssessment", "id": "179698", "meta": {"versionId": "5", "lastUpdated": "2024-12-12T13:30:04.381Z", "profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/adaptation"]}, "extension": [{"url": "http://hl7.org/fhir/StructureDefinition/artifact-author", "valueContactDetail": {"name": "Joanne Dehnbostel"}}, {"url": "http://hl7.org/fhir/StructureDefinition/artifact-description", "valueMarkdown": "This example of an Adaptation Profile shows the specific content that was changed when adapting one Recommendation Profile instance to create a new Recommendation Profile instance, serving a role of 'track changes' for structured data."}, {"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/artifact-publication-status", "valueCodeableConcept": {"coding": [{"system": "http://terminology.hl7.org/CodeSystem/cited-artifact-status-type", "code": "active", "display": "Active"}]}}], "identifier": [{"type": {"text": "FEvIR Object Identifier", "coding": [{"system": "http://terminology.hl7.org/CodeSystem/v2-0203", "code": "ACSN", "display": "Accession ID"}]}, "system": "https://fevir.net/FOI", "value": "179698", "assigner": {"display": "Computable Publishing LLC"}}], "title": "Joanne Dehnbostel's Adaptation Report of Recommendation: ADA Obesity Management Recommendation 8.16", "artifactReference": {"reference": "Composition/179466", "type": "Composition", "display": "Recommendation: ADA Obesity Management Recommendation 8.16"}, "content": [{"type": {"text": "adapted element"}, "classifier": [{"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "string-datatype", "display": "string Datatype"}]}], "path": ["overallSummary"], "component": [{"summary": "8.16 Metabolic surgery should be a recommended option to treat type 2 diabetes in screened surgical candidates with BMI \u226540 kg/m2 (BMI \u226537.5 kg/m2 in Asian Americans) and in adults with BMI 35.0\u201339.9 kg/m2 (32.5\u201337.4 kg/m2 in Asian Americans) who do not achieve durable weight loss and improvement in comorbidities (including hyperglycemia) with nonsurgical methods. A", "type": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "OriginalResourceContent", "display": "Original Resource Content"}]}}, {"type": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "RationaleForChange", "display": "Rationale for Change to Resource Content"}]}, "classifier": [{"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "suggested-change", "display": "Suggested change"}]}]}, {"summary": "8.16 Metabolic surgery should be a recommended option to treat type 2 diabetes in screened surgical candidates with BMI \u226540 kg/m2 (BMI \u226537.5 kg/m2 in Asian Americans) and in adults with BMI 35.0\u201339.9 kg/m2 (32.5\u201337.4 kg/m2 in Asian Americans) who do not achieve durable weight loss and improvement in comorbidities (including hyperglycemia) with nonsurgical methods.", "type": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "SuggestedChange", "display": "Suggested Change to Resource Content"}]}}]}], "modifierExtension": [{"url": "http://hl7.org/fhir/StructureDefinition/artifact-status", "valueCode": "active"}]}